Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline
Details
Publication Year 2023-01,Volume 34,Issue #1,Page 33-47
Journal Title
Annals of Oncology
Publication Type
Guideline
Publisher
Elsevier
Keywords
Humans; Female; Early Detection of Cancer; *Breast Neoplasms/diagnosis/genetics/prevention & control; *Neoplastic Syndromes, Hereditary; *Ovarian Neoplasms/diagnosis/epidemiology/genetics; Risk Reduction Behavior; Genetic Predisposition to Disease; Brca; ESMO Clinical Practice Guideline; hereditary breast and ovarian cancer syndromes; risk reduction
Department(s)
Medical Oncology
PubMed ID
36307055
Open Access at Publisher's Site
http://doi.org/10.1016/j.annonc.2022.10.004
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-06-13 07:55:27
Last Modified: 2024-07-16 06:25:58

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙